Ziopharm Oncology reported $-22670000 in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Amgen AMGN:US $ 1884M 1420M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
AstraZeneca AZN:LN -1652M 2202M
Baxter International BAX:US $ 450M 152M
Biogen BIIB:US $ 329.2M 119.3M
Bristol Myers Squibb BMY:US $ 1546M 491M
Corcept Therapeutics CORT:US $ 30.47M 3.95M
Curis CRIS:US $ -11.05M 0.21M
Eleven Biotherapeutics EBIO:US $ 71.67M 97.12M
Gilead Sciences GILD:US $ 2592M 1070M
GlaxoSmithKline GSK:LN 1168M 227M
Immunogen IMGN:US $ -37.34M 6.6M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Johnson & Johnson JNJ:US $ 3667M 2611M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Merk MRK:US $ 4567M 3022M
Novartis NOVN:VX SF 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Tg Therapeutics TGTX:US $ -85.64M 7.14M
Verastem VSTM:US $ -22.79M 5.88M
YTE INCY:US $ 181.74M 32.28M